Publications by authors named "Carol Broderick"

Claim this Profile
C
Circulating αKlotho influences phosphate handling by controlling FGF23 production.
Rosamund C Smith, Linda M O'Bryan, Emily G Farrow, Lelia J Summers, Erica L Clinkenbeard, Carol Broderick

J Clin Invest· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.
Sean R Werner, Joy K Saha, Carol L Broderick, Eugene Y Zhen, Richard E Higgs

J Mol Neurosci· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Damage to superior parietal cortex impairs pointing in the sagittal plane.
James Danckert, Lana Goldberg, Carol Broderick

Exp Brain Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists.
Qing Shi, Emily J Canada, Yanping Xu, Alan M Warshawsky, Garret J Etgen, Carol L Broderick

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neglected time: impaired temporal perception of multisecond intervals in unilateral neglect.
James Danckert, Susanne Ferber, Carson Pun, Carol Broderick, Christopher Striemer

J Cogn Neurosci· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of a novel class of dual PPARgamma/delta agonists.
Isabel C Gonzalez, Jason Lamar, Fatima Iradier, Yanping Xu, Leonard L Winneroski, Carol L Broderick

Bioorg Med Chem Lett· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.
Yanping Xu, Garret J Etgen, Carol L Broderick, Emily Canada, Isabel Gonzalez

J Med Chem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Mark D Leibowitz, Robert J Ardecky, Marcus F Boehm, Carol L Broderick, Mark A Carfagna

Endocrinology· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
Yanping Xu, Christopher J Rito, Garret J Etgen, Robert J Ardecky, James S Bean, Carol L Broderick

J Med Chem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose stimulates the tyrosine phosphorylation of Crk-associated substrate in pancreatic beta-cells.
Robert J Konrad, Gerald Gold, Thomas N Lee, Robert Workman, Carol L Broderick

J Biol Chem· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.
Guoqing Cao, Yu Liang, Carol L Broderick, Brian A Oldham, Thomas P Beyer

J Biol Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
Garret J Etgen, Brian A Oldham, William T Johnson, Carol L Broderick, Chahrzad R Montrose

Diabetes· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis